Are you looking for an early-stage investment opportunity in a groundbreaking project that's set to revolutionize transplantation medicine and shape the future of healthcare? Join us for an exclusive online webinar hosted by the Spanish-Swedish Chamber of Commerce in collaboration with VERIGRAFT on Wednesday, March 5th, 2025 at 18:00 (6PM CET).
Discover a unique opportunity to invest in a pioneering biotech company that is revolutionizing treatment for cardiovascular disease with personalized tissue engineered grafts that eliminate the need for immunosuppression and reduce risks of rejection and infection. VERIGRAFT clinical trials and product manufacturing are taking place in Spain, positioning the company at the forefront of medical innovation.
Following the success of their recent investor event at the Embassy of Sweden in Madrid, this webinar will cover all aspects of VERIGRAFT’s commercial goals and provide an in-depth look at potential investment opportunities for private investors, starting at 1,000€, available through this crowd investment.
Time: 18:00 (6PM CET)
Date: Wednesday, March 5th
Place: Online (Zoom)
What to Expect:
• Welcome by the Spanish-Swedish Chamber of Commerce
• Presentations from VERIGRAFT's CEO & CTO
• Detailed explanation of how private individuals can invest and become shareholders
• Insights into our innovative technology and business potential
• Live Q&A session
Key Speakers from VERIGRAFT:
• Petter Björquist, PhD, CEO – former AstraZeneca and Cellartis/Cellectis
• Raimund Strehl, PhD, CTO – former Cellartis/Cellectis
Register Now - Sign up through the following link: https://us02web.zoom.us/meeting/register/nuQ_qkBzTLeURxhnx0EMcg
A Zoom link will be provided upon registration.
Don't miss this chance to invest in a visionary company at the forefront of personalized medicine!
